Skip to Content
CancersCancers
  • Erratum
  • Open Access

29 June 2020

Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713

,
,
,
,
,
,
,
,
1
IrsiCaixa AIDS Research Institute, Badalona, 08916 Catalonia, Spain
2
Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain
3
Institut Català d’Oncologia, Badalona, 08916 Catalonia, Spain
4
Cienciatraducida, 08391 Barcelona, Spain
The authors wish you make the following corrections to this paper [1].
One contributor’s name was missing in the original version of the authorship. The original version of the authorship is:
Marc Castellví 1,2,†, Eudald Felip 2,3,†, Ifeanyi Jude Ezeonwumelu 1,2, Roger Badia 1,2, Edurne Garcia-Vidal 1,2, Maria Pujantell 1,2, Lucía Gutiérrez-Chamorro 1,2, Iris Teruel 2,3, Anna Martínez-Cardús 2,3, Bonaventura Clotet 1,2, Eva Riveira-Muñoz 1,2, Mireia Margelí 2,3 and Ester Ballana 1,2,*
and should be replaced with:
Marc Castellví 1,2,†, Eudald Felip 2,3,†, Ifeanyi Jude Ezeonwumelu 1,2, Roger Badia 1,2, Edurne Garcia-Vidal 1,2, Maria Pujantell 1,2, Lucía Gutiérrez-Chamorro 1,2, Iris Teruel 2,3, Anna Martínez-Cardús 2,3, Bonaventura Clotet 1,2, Eva Riveira-Muñoz 1,2, Mireia Margelí 2,3, José A. Esté 1,4, and Ester Ballana 1,2,*
The updated “Author Contributions” should be

Author Contributions

Conceptualization, J.A.E., E.R.-M., M.M and E.B.; Formal analysis, M.M., J.A.E. and E.B.; Investigation, M.C., E.F., I.J.E, R.B, E.G.-V., M.P. and L.G.-C-; Methodology, I.T. and A.M.-C.; Supervision, B.C. and J.A.E.; Writing – original draft, E.B. and J.A:E.; Writing – review & editing, E.R.-M. and E.B. All authors have read and agreed to the published version of the manuscript

Reference

  1. Castellví, M.; Felip, E.; Ezeonwumelu, I.J.; Badia, R.; Garcia-Vidal, E.; Pujantell, M.; Gutiérrez-Chamorro, L.; Teruel, I.; Martínez-Cardús, A.; Clotet, B.; et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713. [Google Scholar] [CrossRef]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.